Pfizer: all 4,072 studies
Page 29 of 41. Open to participants first (153), then studies with results posted, then the rest; newest registration first within each.
- A Single Dose Study In Japanese And Western Healthy Subjects To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-04991532CompletedNCT01369277Phase 1
- A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its AbsorptionCompletedNCT01366287Phase 1
- A Study of ARRY-371797 in Patients With Osteoarthritis of the KneeCompletedNCT01366014Phase 2
- The Safety and Tolerability of PF-05089771 Will be Investigated in Healthy Subjects Over a 14 Day Dosing Period.CompletedNCT01365637Phase 1
- Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 YearsCompletedNCT01364571Phase 1
- A Study To Determine Effects Of Fluticasone Propionate On Sputum Neutrophils After Inhaled Lipopolysaccharide Challenge In VolunteersCompletedNCT01364519Phase 1
- Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized PatientsCompletedNCT01363271
- Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor PatientsCompletedNCT01363232Phase 1
- PK And Safety Study Of PF-04171327 In Healthy Japanese And Western Subjects In Fasting And Fed ConditionsCompletedNCT01362673Phase 1
- A Study to Evaluate Infants With Potential Exposure to Tanezumab Before BirthCompletedNCT01362660
- A Study To Determine Bioequivalence Between The Commercial Femulen Tablets And A Reformulation Of Femulen Tablets In Healthy Female SubjectsCompletedNCT01359163Phase 1
- Pharmacokinetics Of Orally Administered Fx-1006A In Subjects With Hepatic DysfunctionCompletedNCT01358565Phase 1
- Heat Wrap Device Safety With Age and Body FatCompletedNCT01355653Not applicable
- MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E MutationsCompletedNCT01352273Phase 1
- Single Dose Study To Compare Pharmacokinietics Of 3 Different Formulations Of PF-04991532 In Healthy VolunteersCompletedNCT01351129Phase 1
- A Bioequivalence Study Of Ibuprofen 50mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form.CompletedNCT01350596Phase 4
- A Safety Study of ARRY-502 in Healthy SubjectsCompletedNCT01349725Phase 1
- Assessment Of The Effects Of Single Doses Of An Investigational Drug, Given Alone Or With Donepezil, On Scopolamine-Induced Changes In Memory And Learning In Healthy AdultsTerminatedNCT01345864Phase 1
- Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2.CompletedNCT01339962
- National Trends in Otitis Media in Children Under 5 Years of AgeCompletedNCT01339546
- Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor PatientsCompletedNCT01337765Phase 1
- Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate CombinationCompletedNCT01321463Phase 2
- Study To Investigate The Potential Drug Drug Interaction (DDI) Between PF-00299804 And Paroxetine In Healthy SubjectsCompletedNCT01318031Phase 1
- A Study of ARRY-382 in Patients With Selected Advanced or Metastatic CancersCompletedNCT01316822Phase 1
- A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy VolunteersCompletedNCT01314898Phase 1
- Single Dose Lipopolysaccharide (LPS) Study In Healthy VolunteersCompletedNCT01314885Phase 1
- A Bioequivalence (BE) Study Comparing The Commericializable And Clinical Formulations Of PF-00299804CompletedNCT01313793Phase 1
- Study Evaluating Local Susceptibility Patterns Associated With Tigecycline in Comparison to Other AntibioticsCompletedNCT01311349
- A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell NeoplasmsCompletedNCT01309789Phase 1
- Long-Term Safety Of DVS-233 SR In Patients With Major Depressive DisorderCompletedNCT01309542Phase 3
- A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen ChallengeWithdrawnNCT01299467Phase 1
- A Study To Investigate The Safety And Toleration Of Multiple Oral Doses Of PF-03654764 In Combination With Fexofenadine In Healthy SubjectsTerminatedNCT01298505Phase 1
- Sayana-Uniject Volumetric DeliveryCompletedNCT01298479
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of NXL104 Alone and in Combination With Ceftazidime Administered as Single and Repeated Intravenous Doses in Healthy Japanese SubjectsCompletedNCT01291602Phase 1
- A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male VolunteersCompletedNCT01290900Phase 1
- Study To Evaluate The Effect Of Single Intravenous Doses Of Tigecycline On QTc Intervals In Healthy SubjectsCompletedNCT01287793Phase 1
- A Study To Compare The Amount Of CP-690,550 That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Two Different Strength Tablets Of CP-690,550CompletedNCT01277991Phase 1
- A Study Of PF-05175157 In Healthy VolunteersCompletedNCT01274663Phase 1
- This Study Is To Estimate The Time Course Of Pf-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder InhalersCompletedNCT01272375Phase 1
- The Pharmacokinetics and Safety Characteristics of Docetaxel in Patients With CancerCompletedNCT01268163Phase 1
- Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese SubjectsCompletedNCT01268124Phase 1
- A Comparison Of The Pharmacokinetics Of PF-04191834 Following Single Dose Administration Of A Dispersion Formulation And A Suspension Formulation In Healthy VolunteersWithdrawnNCT01265732Phase 1
- A Study In Healthy Subjects Of Single Doses of PF-05230901 Injected Under The SkinTerminatedNCT01262690Phase 1
- Safety And Efficacy Of Spirinolactone Plus Hydroflumethiazide In The Treatment Of Filipino Patients With HypertensionWithdrawnNCT01260857
- A Bioequivalence Study Of Ethinylestradiol + Gestodene In Female And Healthy Volunteers.CompletedNCT01260805Phase 1
- A Single Dose Escalation Study In Healthy Volunteers To Determine The Pharmacokinetics, Safety And Tolerability Of PF-05089771 In Healthy VolunteersCompletedNCT01259882Phase 1
- This Study Will Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy VolunteersCompletedNCT01258751Phase 1
- Safety Study of Ointment for the Treatment of Plaque-type PsoriasisCompletedNCT01258088Phase 1
- To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy VolunteersCompletedNCT01253655Phase 1
- Phase 1 and 2 Study of PX-866 and CetuximabCompletedNCT01252628Phase 1/2
- Drug Interaction Between Ritonavir And SitaxsentanWithdrawnNCT01251848Phase 1
- Effect Of Rifampin On Pharmacokinetics Of SitaxsentanWithdrawnNCT01251835Phase 1
- A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple MyelomaCompletedNCT01248923Phase 1
- Single Dose Escalation Study of PF-05190457 in Healthy VolunteersCompletedNCT01247896Phase 1
- A Comparison Of A Single PF-04634817 Tablet Dose Compared With A Solution In Healthy VolunteersCompletedNCT01247883Phase 1
- Effects Of PF-02545920 On Ketamine-Induced Abnormal Prefrontal Brain Response To Associative Learning In Healthy SubjectsTerminatedNCT01244880Phase 1
- A Study Evaluating the Absorption Of Varenicline Through The Skin Following Once Daily Application Of A Patch For 14 DaysCompletedNCT01234142Phase 1
- Bosutinib In Subjects With Renal ImpairmentCompletedNCT01233882Phase 1
- Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy SubjectsCompletedNCT01230385Phase 1
- A Study In Healthy Volunteers To Assess The Safety, Tolerability, And Relative Oral Bioavailability Of Three Formulations Of PH-797804CompletedNCT01226693Phase 1
- A Study Of Tasocitinib In Dry Eye SubjectsWithdrawnNCT01226680Phase 2
- A Trial Of PF-04856884 In Patients With Recurrent GlioblastomaWithdrawnNCT01225510Phase 2
- Retrospective Study Evaluating The Current Utilization Of Desvenlafaxine Succinate Sustained-Release (Pristiq) Among Psychiatrists And Primary Care Physicians In The Treatment Of Patients With Major Depressive DisorderCompletedNCT01221935
- Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy SubjectsCompletedNCT01220232Phase 1
- NeisVac-C Single Prime Study in InfantsCompletedNCT01218451Phase 3
- Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult SubjectsCompletedNCT01217918Phase 1
- Scopolamine Challenge StudyCompletedNCT01213355Phase 1
- Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone MaintenanceCompletedNCT01210404Phase 1
- Estimate The Effect Of Repeat-Dose Rifampin On The Pharmacokinetics Of CP-690,550 In Healthy VolunteersCompletedNCT01204112Phase 1
- Study of PX-866 and Docetaxel in Solid TumorsCompletedNCT01204099Phase 1/2
- A Multiple Dose Study Of PF-05161704 In Healthy VolunteersTerminatedNCT01202266Phase 1
- Effect Of Ketoconazole On The Pharmacokinetics Of Tasocitinib (CP-690,550) In Healthy VolunteersCompletedNCT01202240Phase 1
- Single Dose Study Of PF-04171327 And Prednisone On Carbohydrate MetabolismCompletedNCT01199900Phase 1
- Single Dose Study Of PF-04308515 And Prednisone On CarbohydrateCompletedNCT01199029Phase 1
- A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001No longer availableNCT01196208
- Study In Healthy Subjects To Evaluate The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274CompletedNCT01193062Phase 1
- Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric SubjectsWithdrawnNCT01188759Phase 3
- Multiple Dose Healthy Volunteer Study of PF-03715455.CompletedNCT01186757Phase 1
- Pharmacokinetics And Safety Study Of Two CP-690,550 Controlled Release Formulation Following Single Dose In Healthy VolunteersCompletedNCT01185184Phase 1
- A Study To Compare The Amount Of Tasocitinib (CP-690,550) That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Three Different Tablet Versions Of Tasocitinib (CP-690,550)CompletedNCT01184092Phase 1
- A Study To Evaluate The Effect Of Food On How Tasocitinib (CP-690,550) Is Absorbed And Moves Through The Body Following Oral Administration Of Tasocitinib (CP-690,550) Tablets To Healthy SubjectsCompletedNCT01184001Phase 1
- A Single Dose Study Of PF-05161704 In Healthy VolunteersCompletedNCT01183715Phase 1
- Safety, Tolerability and Relative Bioavailability of Pegvisomant in Healthy SubjectsCompletedNCT01181973Phase 1
- A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood After Dosing With Oral Inhalation From Dry Powder InhalersCompletedNCT01181700Phase 1
- To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy VolunteersCompletedNCT01173757Phase 1
- A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance TreatmentCompletedNCT01170078Phase 1
- A Study To Observe Safety And Blood Concentrations Of PF-04995274 During And Following the Administration of Multiple Doses Of PF-04995274 In Healthy Adult And Healthy Elderly Volunteers.CompletedNCT01169714Phase 1
- Study to Evaluate Hemodynamic Effect of Different Loading Doses of Precedex in Post-surgical Intensive Care Unit (ICU) PatientsCompletedNCT01169571
- Pharmacokinetics And Tolerability Of Subcutaneous Administration Of PF 04236921 In Healthy VolunteersCompletedNCT01166555Phase 1
- A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric AdenocarcinomaCompletedNCT01166490Phase 1
- A Single Dose Study Of PF-04620110 In Healthy SubjectsCompletedNCT01166217Phase 1
- To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological ActivityCompletedNCT01165736Phase 1
- A Clinical Study Evaluating The Safety And Tolerability Of PF-04427429 In Healthy Adult Volunteers. The Pharmacokinetics And Pharmacodynamics Of PF-04427429 Will Also Be InvestigatedCompletedNCT01165723Phase 1
- Multiple-Dose Safety Study Of RN316 For TheTreatment Of HypercholesterolemiaWithdrawnNCT01163838Phase 1
- Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy PeopleTerminatedNCT01162889Phase 1
- A Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03049423 In Healthy Adult Volunteers And Healthy Older VolunteersCompletedNCT01161069Phase 1
- Pharmacokinetics, Safety and Tolerability Study of PF-03463275 in Healthy Male Japanese and Western SubjectsCompletedNCT01159626Phase 1
- Multiple Ascending Dose Study To Assess Safety, Tolerability And Pharmacokinetics Of PF-05212377 (SAM-760)CompletedNCT01159496Phase 1
- An Extension of the CONCERT Protocol (DIM18)TerminatedNCT01152216Phase 3
- Acute Response Capsaicin Flare StudyCompletedNCT01147432Phase 1